Knowledge Center

Patent / Sep 30, 2021

Compositions for use in treating meibomian gland dysfunction

Authors:
  • Carla Vozone
  • Mohammad Salman
  • George Magrath
  • Courtney Smith
Source:
WO 2021191273

The invention provides methods, compositions, and kits containing a minocycline topical suspension, for treating meibomian gland dysfunction and related disorders.

Also in the Knowledge Center

Related Content

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Spray drying

Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.

Page
Read more

Regulatory Affairs

Hovione has filings with every world health authority that has a DMF system for APIs including FDA EDQM PMDA,MHRA, HPRA, Infarmed among others.

Page
Read more